Reliability on bioequivalence test to be strengthened

The Korea Food and Drug Administration (KFDA) said that although it allows the corresponding pharmaceutical firms to perform the bioequivalence tests using their existing labs and personnel in a bid to promote the tests, they will be only permitted to analyze the plasma concentration of test drug in subjects from the whole procedures ranging from supply of specimens and final report of a clinic...